查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392721

吸入麻醉全球市場報告 2024年

Inhalation Anesthesia Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，吸入麻醉的市場規模強勁成長。將從2023年的14.6億美元擴大到2024年的15.6億美元，年複合成長率為7.1%。過去一段時間的擴張是由於對需要麻醉的外科手術的需求增加，老年人口不斷成長，吸入麻醉劑開發的進步，門診手術中心的激增以及心臟病和癌症等慢性疾病盛行率上升所致。

慢性病的預期增加將推動吸入麻醉市場的成長。慢性病的特徵是長期持續超過3個月，往往需要手術介入診斷、治療和管理。吸入麻醉對於在此類手術過程中為患者提供舒適度和安全性變得非常重要。根據美國國家醫學圖書館2023年1月發布的報告，預計美國50歲及以上患有一種或多種慢性病的人數將增加99.5%，從2020年的71,522,000人增加到美國年的71,522,000人。達到142666人增加到2050年的71,522,000人。萬人。因此，慢性病的增加預計將推動吸入麻醉市場的成長。

2023年，北美是吸入麻醉市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。

目錄

第1章 執行摘要

第2章 吸入麻醉市場特點

第3章 吸入麻醉市場趨勢與策略

第4章 吸入麻醉市場-宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章 全球吸入麻醉市場規模與成長

  • 市場促進因素/市場抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023年市場規模與成長表現
  • 市場規模與成長預測，2023-2028，2033F

第6章 吸入麻醉市場區隔

  • 全球吸入麻醉市場，依產品、性能及預測細分，2018-2023、2023-2028F、2033F
  • SEVOFLURANE
  • DESFLURANE
  • Isoflurane
  • 氧化亞氮
  • 全球吸入麻醉市場，依應用、性能和預測細分，2018-2023、2023-2028F、2033F
  • 誘導
  • 維護
  • 全球吸入麻醉市場，依最終用戶細分，實際和預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 門診手術中心

第7章 吸入麻醉市場區域與國家分析

  • 全球吸入麻醉市場，依地區，實績和預測，2018-2023、2023-2028F、2033F
  • 全球吸入麻醉市場，依國家、績效及預測，2018-2023、2023-2028F、2033F

第8章 亞太吸入麻醉市場

  • 概述
  • 區域資訊、COVID-19 影響、市場資訊、背景資訊、政府措施、法規、監管機構、關鍵機構、課稅、公司稅務結構、投資、主要企業
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第9章 中國吸入麻醉市場

第10章 印度吸入麻醉市場

第11章 日本吸入麻醉市場

第12章 澳洲吸入麻醉市場

第13章 印尼吸入麻醉市場

第14章 韓國吸入麻醉市場

第15章 西歐吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第16章 英國吸入麻醉市場

第17章 德國吸入麻醉市場

第18章 法國吸入麻醉市場

第19章 義大利吸入麻醉市場

第20章 西班牙吸入麻醉市場

第21章 東歐吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第22章 俄羅斯吸入麻醉市場

第23章 北美吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第24章 美國吸入麻醉市場

第25章 加拿大吸入麻醉市場

第26章 南美洲吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第27章 巴西吸入麻醉市場

第28章 中東吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第29章 非洲吸入麻醉市場

  • 概述
  • 依產品細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依應用細分，實績和預測，2018-2023、2023-2028F、2033F
  • 依最終用戶細分，實績和預測，2018-2023、2023-2028F、2033F

第30章 吸入麻醉市場競爭形勢及公司概況

  • 吸入麻醉市場競爭形勢
  • 吸入麻醉市場公司概況
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE &Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC

第31章 全球吸入麻醉市場競爭基準化分析

第32章 全球吸入麻醉市場競爭儀表板

第33章 吸入麻醉市場重大併購

第34章 吸入麻醉市場未來前景及潛力分析

第35章 附錄

簡介目錄
Product Code: r10409

“Inhalation Anesthesia Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation anesthesia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation anesthesia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inhalation anesthesia market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
  • 2) By Application: Induction; Maintenance
  • 3) By End User: Hospitals; Ambulatory Surgical Centers
  • Companies Mentioned: Abbvie Inc.; Baxter International Inc.; Fresenius SE & Co. KGaA; Halocarbon Products Corporation; Hikma Pharmaceuticals PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Inhalation anesthesia pertains to medications administered in operating rooms for the purpose of initiating and sustaining general anesthesia. Alongside other therapeutic effects, it induces varying degrees of drowsiness, ranging from mild to profound, ultimately achieving a state of general anesthesia. Inhalation anesthesia finds application in both the induction and maintenance phases of general anesthesia within the operating room.

Key products in the realm of inhalation anesthesia include sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane, specifically, is an inhaled general anesthetic employed for the initiation and upkeep of general anesthesia. Its action involves muscle relaxation and a reduction in pain sensitivity through the modification of tissue excitability. The uses of inhalation anesthesia encompass both the induction and maintenance phases, and the primary end-users are hospitals and ambulatory surgical centers.

The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides Inhalation anesthesia market statistics, including inhalation anesthesia industry global market size, regional shares, competitors with an inhalation anesthesia market share, detailed inhalation anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. This inhalation anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhalation anesthesia market size has grown strongly in recent years. It will grow from $1. 46 billion in 2023 to $1. 56 billion in 2024 at a compound annual growth rate (CAGR) of 7. 1%. The expansion observed during the historical period can be attributed to the increasing demand for surgical procedures necessitating anesthesia, a growing geriatric population, advancements in the development of inhalation anesthetics, the proliferation of ambulatory surgical centers, and a rising prevalence of chronic diseases such as heart disease and cancer.

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2. 14 billion in 2028 at a compound annual growth rate (CAGR) of 8. 2%. The anticipated growth in the forecast period can be attributed to an increasing demand for minimally invasive surgeries, a rise in global healthcare expenditure, a growing number of surgical procedures in emerging markets, the adoption of inhalation anesthesia in veterinary medicine, and an augmentation in government funds allocated for the research and development of innovative inhalation anesthetics. Prominent trends expected in the forecast period encompass technological innovations in anesthesia delivery systems, the development of inhalation anesthesia devices tailored for pediatric use, a shift towards the usage of sevoflurane and desflurane, a heightened focus on eco-friendly anesthetic agents, and the integration of monitoring technologies in anesthesia delivery.

The anticipated growth in the geriatric population is set to drive the inhalation anesthesia market during the forecast period. The increasing number of elderly individuals contributes to the expansion of the inhalation anesthesia market as this demographic is more susceptible to degenerative diseases and chronic illnesses, leading to a heightened demand for surgeries and therapeutic interventions. The rise in the geriatric population, prone to ailments like cardiovascular, neurological, respiratory, and degenerative disorders, plays a significant role in boosting market growth. Administering anesthesia through an intravenous route to geriatric patients can be inconvenient due to issues with punctured blood vessels and patient compliance. For example, as of October 2022, the World Health Organization reports a projected global population of 1. 4 billion individuals aged 60 years by 2022 compared to 1 billion in 2020. Additionally, it is estimated that by 2030, one out of every six people worldwide will be aged 60 years or older. Consequently, the increasing geriatric population is expected to drive the demand for inhalation anesthesia throughout the forecast period.

The expected increase in chronic diseases is poised to fuel the growth of the inhalation anesthesia market. Chronic diseases, characterized by long-term persistence over three months or more, often necessitate surgical interventions for diagnosis, treatment, or management. Inhalation anesthesia becomes crucial in providing comfort and safety to patients during these surgical procedures. A report from the National Library of Medicine, published in January 2023, projects a 99. 5% increase in the number of individuals aged 50 years and older with one or more chronic illnesses, reaching 142. 66 million by 2050 in the United States, up from 71. 522 million in 2020. As a result, the upsurge in chronic diseases is expected to propel the growth of the inhalation anesthesia market.

In response to industry demands and to strengthen their market positions globally, numerous companies in the inhalation anesthesia sector are developing innovative products like Sedaconda. Sedaconda, an inhaled sedation therapy delivered through the Anaesthetic Conserving Device (ACD), received approval for use in intensive care. For example, in February 2022, Sedana Medical AB, a Sweden-based med-tech and pharmaceutical company, introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) is administered using the medical device known as Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy authorized for use in intensive care settings.

Leading companies in the inhalation anesthesia market are channeling their efforts into developing innovative products such as end-tidal (ET) control software to enhance their offerings. The End-tidal (Et) Control software, designed for administering general anesthesia through the Aisys CS2 Anesthesia Delivery System, received FDA pre-market approval (PMA) from GE Healthcare Technologies Inc., a US-based medical technology company, in April 2022. This software facilitates semi-automated anesthesia administration by enabling anesthesia providers to set and maintain end-tidal oxygen and anesthetic agent targets, improving precision in inhalation anesthesia delivery, streamlining workflows, reducing drug wastage, and contributing to cost savings and reduced greenhouse gas emissions in healthcare settings.

In January 2022, Dechra Pharmaceuticals, a UK-based specialist veterinary pharmaceuticals and related products business, acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. This acquisition adds Isoflurane and Sevoflurane to Dechra's pharmaceutical companion animal portfolio, focusing on areas such as endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in supplying isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications.

Major companies operating in the in the inhalation anesthesia market report are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

North America was the largest region in the inhalation anesthesia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Inhalation Anesthesia Market Characteristics

3. Inhalation Anesthesia Market Trends And Strategies

4. Inhalation Anesthesia Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Inhalation Anesthesia Market Size and Growth

  • 5.1. Global Inhalation Anesthesia Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Inhalation Anesthesia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Inhalation Anesthesia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inhalation Anesthesia Market Segmentation

  • 6.1. Global Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
  • 6.2. Global Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Induction
  • Maintenance
  • 6.3. Global Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers

7. Inhalation Anesthesia Market Regional And Country Analysis

  • 7.1. Global Inhalation Anesthesia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Inhalation Anesthesia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inhalation Anesthesia Market

  • 8.1. Asia-Pacific Inhalation Anesthesia Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inhalation Anesthesia Market

  • 9.1. China Inhalation Anesthesia Market Overview
  • 9.2. China Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inhalation Anesthesia Market

  • 10.1. India Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inhalation Anesthesia Market

  • 11.1. Japan Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inhalation Anesthesia Market

  • 12.1. Australia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inhalation Anesthesia Market

  • 13.1. Indonesia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inhalation Anesthesia Market

  • 14.1. South Korea Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inhalation Anesthesia Market

  • 15.1. Western Europe Inhalation Anesthesia Market Overview
  • 15.2. Western Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inhalation Anesthesia Market

  • 16.1. UK Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inhalation Anesthesia Market

  • 17.1. Germany Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inhalation Anesthesia Market

  • 18. 5. France Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inhalation Anesthesia Market

  • 19. 9. Italy Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inhalation Anesthesia Market

  • 20.13. Spain Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inhalation Anesthesia Market

  • 21.1. Eastern Europe Inhalation Anesthesia Market Overview
  • 21.2. Eastern Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inhalation Anesthesia Market

  • 22.1. Russia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inhalation Anesthesia Market

  • 23.1. North America Inhalation Anesthesia Market Overview
  • 23.2. North America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inhalation Anesthesia Market

  • 24.1. USA Inhalation Anesthesia Market Overview
  • 24.2. USA Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inhalation Anesthesia Market

  • 25.1. Canada Inhalation Anesthesia Market Overview
  • 25.2. Canada Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inhalation Anesthesia Market

  • 26.1. South America Inhalation Anesthesia Market Overview
  • 26.2. South America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inhalation Anesthesia Market

  • 27.1. Brazil Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inhalation Anesthesia Market

  • 28.1. Middle East Inhalation Anesthesia Market Overview
  • 28.2. Middle East Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inhalation Anesthesia Market

  • 29.1. Africa Inhalation Anesthesia Market Overview
  • 29.2. Africa Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inhalation Anesthesia Market Competitive Landscape And Company Profiles

  • 30.1. Inhalation Anesthesia Market Competitive Landscape
  • 30.2. Inhalation Anesthesia Market Company Profiles
    • 30.2.1. Abbvie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Baxter International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Fresenius SE & Co. KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Halocarbon Products Corporation
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Hikma Pharmaceuticals PLC
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Inhalation Anesthesia Market Competitive Benchmarking

32. Global Inhalation Anesthesia Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

34. Inhalation Anesthesia Market Future Outlook and Potential Analysis

  • 34.1 Inhalation Anesthesia Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Inhalation Anesthesia Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Inhalation Anesthesia Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer